Bubble Fade Away Acne Spot Treatment

Manufacturer
BUBBLE BEAUTY
Effective date
2025-01-20
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:53:18

Label at a glance#

ProductBubble Fade Away Acne Spot Treatment
Active ingredientBENZOYL PEROXIDE
Label structure9 sections

Indications and uses

For the treatment of acne Helps clear acne blemishes, acne pimples, blackheads, and whiteheads and allows skin to heal.

Dosage and administration

Clean the skin thoroughly before applying this product. Cover the entire affected area with a thin layer one to three times daily. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Benzoyl Peroxide 5%

Purpose

OTC - PURPOSE SECTION

Acne Medication

Uses

INDICATIONS & USAGE SECTION

  • For the treatment of acne
  • Helps clear acne blemishes, acne pimples, blackheads, and whiteheads and allows skin to heal.

Warnings

WARNINGS SECTION

For external use only.

Do not use if you

OTC - DO NOT USE SECTION

  • have very sensitive skin
  • are sensitive to benzoyl peroxide

When using this product

OTC - WHEN USING SECTION

  • skin irritation or dryness may occur if you use another topical acne medication at the same time. If irritation occurs, use one medication at a time
  • avoid unnecessary sun exposure and use a sunscreen
  • avoid contact with the eyes, lips, and mouth
  • avoid contact with hair and dyed fabrics, which may be bleached
  • redness, burning, itching, peeling, or possibly swelling may occur. Irritation may be reduced by using the product less or in a lower concentration.

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • irritation becomes severe.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • Clean the skin thoroughly before applying this product.
  • Cover the entire affected area with a thin layer one to three times daily.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
  • If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Other information

OTHER SAFETY INFORMATION

  • Avoid storing at extreme temperatures (Below 40F and above 100F).

Inactive ingredients

INACTIVE INGREDIENT SECTION

Water (Aqua), Glycerin, Propanediol, Carbomer, Glycyrrhiza Glabra (Licorice) Root Extract, Niacinamide, Allantoin, Zinc Pca, Laureth-4, Xanthan Gum, Aloe Barbadensis Leaf Juice, Diethylhexyl Sodium Sulfosuccinate, Sambucus Nigra Fruit Juice, Spiraea Ulmaria Flower Extract, Sodium Hydroxide, Sodium Citrate, Sodium Phytate, Potassium Sorbate, Citric Acid, Sodium Benzoate, Sodium Sulfite

Questions or comments?

OTC - QUESTIONS SECTION

Call +1 (651) 504-2243

Product Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
106309benzoyl peroxide 5 % Topical LotionPSN1
106309benzoyl peroxide 50 MG/ML Topical LotionSCD1
106309benzoyl peroxide 5 % Topical LotionSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a46239a7-5963-4008-8cbb-6b9000f497ebProduct name120250721
b382b4e1-6b48-45f6-bffc-e61b00b0ce19Product name320250317
d9d61457-6a5a-41fc-b418-e5479a2904b7Product name220230303
32012d5c-25ac-49c7-9d4c-1313177fff7cProduct name120230112
13e7e7e3-e885-4c79-af6d-dad1aedbb06eProduct name120220128
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
4a7d44fe-774d-404b-aad0-8a90fe78375aProduct name420211025
3f45980c-c196-47e5-0e5e-48b7c57327c5Product name520200428
d12e2d7c-bd6b-45d4-94f9-6df8e1b8b27bProduct name320200203
ee5c6de5-d9cd-454f-b250-7b19e5cf2992Product name420190619
ad75fcfd-a339-42a1-9c60-43ba2c654cfaProduct name120170810
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83509-003-01Bubble Fade Away Acne Spot Treatment1 in 1 CARTONEMULSION11
83509-003-01Bubble Fade Away Acne Spot Treatment10 mL in 1 TUBEEMULSION101

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83509-003BUBBLE FADE AWAY ACNE SPOT TREATMENT (BENZOYL PEROXIDE) EMULSION [BUBBLE BEAUTY]1Current NDC, 2 package rows20250122_2c2dbdc7-8d2e-4ad3-e063-6294a90a6c7e.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 23 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83509-00383509-003-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 22 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Bubble Fade Away Acne Spot TreatmentBENZOYL PEROXIDEBUBBLE BEAUTY2c2dbdc7-8d2e-4ad3-e063-6294a90a6c7e2025-01-20WarningsExact identifier
ndc (package): 83509-003-01
ndc (product): 83509-003
ndc11 (package): 83509000301
spl id: 2c2dbdc7-8d2d-4ad3-e063-6294a90a6c7e
spl set id: 2c2dbdc7-8d2e-4ad3-e063-6294a90a6c7e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.